Finance

Lists
ESLA:NASDAQ
Estrella Immunopharma Inc
$0.41
-1.80%
(-0.0075) 1D
$0.34
-17.05% (-0.070)
After hours
Closed: Oct 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ESLA...
Open
$0.35
High
$0.44
Low
$0.31
Mkt. cap
17.73M
Avg. vol.
41.40K
Volume
19.85M
52-wk high
$3.15
52-wk low
$0.31
EPS
-$0.25
Beta
0.93
Shares outstanding
43.50M
Open
$0.35
High
$0.44
Low
$0.31
Mkt. cap
17.73M
Avg. vol.
41.40K
Volume
19.85M
52-wk high
$3.15
52-wk low
$0.31
EPS
-$0.25
Beta
0.93
Shares outstanding
43.50M
News stories
From web sources and news partners
About Estrella Immunopharma Inc
CEO-
Employees-
Founded2006
HeadquartersEmeryville, California, United States
SectorBiotechnology
Websiteestrellabio.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.15M
25.41K
1.40M
1.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
648.51K
587.78K
891.79K
684.02K
Operating expense
4.80M
613.20K
2.29M
2.08M
Total operating expenses
4.80M
613.20K
2.29M
2.08M
Operating income
-4.80M
-613.20K
-2.29M
-2.08M
Other non operating income
-
-
-
-222.09K
EBT including unusual items
-4.80M
-613.20K
-2.29M
-2.31M
EBT excluding unusual items
-4.80M
-613.20K
-2.29M
-2.31M
Income tax expense
-
-25.00
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.80M
-613.17K
-2.29M
-2.31M
Net profit margin
-
-
-
-
Earnings per share
-0.13
-0.01
-
-0.05
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps